Abstract:Pathogenic Escherichia coli and Salmonella enterica pose serious public health threats due to their ability to cause severe gastroenteritis and life-threatening sequela, particularly in young children. Moreover, the emergence and dissemination of antibiotic resistance in these bacteria have complicated control of infections. Alternative strategies that effectively target these enteric pathogens and negate or reduce the need of antibiotics are urgently needed. Such an alternative is the CRISPR-Cas9 system because it can generate sequence-specific lethal double stranded DNA breaks. In this study, two self-transmissible broad host range conjugative plasmids, pRK24 and pBP136, were engineered to deliver multiplexed CRSIPR-Cas9 systems that specifically target Enterohemorrhagic and Enteropathogenic strains of E . coli (EHEC and EPEC), S . enterica , and bla CMY-2 antibiotic resistance plasmids. Using in vitro mating assays, we show that the conjugative delivery of pRK24-CRISPR-Cas9 carrying guide RNAs to the EPEC/EHEC eae (intimin) gene can selectively kill enterohemorrhagic E . coli O157 eae + cells (3 log kill at 6 h) but does not kill the isogenic Δeae mutant (P<0.001). Similar results were also obtained with a pBP136 derivative, pTF16, carrying multiplexed guide RNAs targeting E . coli eae and the S . enterica ssaN gene coding for the type III secretion ATPase. Another pBP136 derivative, TF18, carries guide RNAs targeting S . enterica ssaN and the antibiotic resistance gene, bla CMY-2 , carried on the multi-drug resistant pAR06302. Introduction of pTF18 into bacteria harboring pAR06302 showed plasmids were cured at an efficiency of 53% (P<0.05). Using a murine neonate EPEC infection model, pTF16 was delivered by a murine derived E . coli strain to EPEC infected mice and showed significant reductions of intestinal EPEC (P<0.05). These results suggest that establishing conjugative CRISPR-Cas9 antimicrobials in the intestinal microbiome may provide protection from enteric pathogens and reduce antibiotic resistance without disrupting the normal microbiota.

Sequential CRISPR-Based Screens Identify LITAF and CDIP1 as the Bacillus cereus Hemolysin BL Toxin Host Receptors

A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome

A multi-component bacterial toxin incites host inflammation via the NLRP3 inflammasome

Design, performance, processing, and validation of a pooled CRISPR perturbation screen for bacterial toxins

Advance in Toxic and Pathogenic Mechanisms of Bacterial Hemolysins

Emerging enterococcus pore-forming toxins with MHC/HLA-I as receptors

Genome-wide dissection reveals diverse pathogenic roles of bacterial Tc toxins

EST-based Genome-Wide Gene Inactivation Identifies ARAP3 As a Host Protein Affecting Cellular Susceptibility to Anthrax Toxin

Identification of a hemorrhagic determinant in Clostridioides difficile TcdA and Paeniclostridium sordellii TcsH

Low-density Lipoprotein Receptor-Related Protein 1 is a CROPs-associated Receptor for Clostridioides Infection Toxin B.

The Application of Genome-wide CRISPR-Cas9 Screens to Dissect the Molecular Mechanisms of Toxins

Genome-Wide Identification of Host Genes Required for Toxicity of Bacterial Cytolethal Distending Toxin in a Yeast Model

Targeting Bacillus Anthracis Toxicity with a Genetically Selected Inhibitor of the PA/CMG2 Protein-Protein Interaction

Toxin-based screening of C-terminal tags in reveals the exceptional potency of ssrA-like degrons

DnaJ and ClpX are required for HitRS and HssRS two-component system signaling in Bacillus anthracis

LITAF protects against pore-forming protein–induced cell death by promoting membrane repair

A High-Homology Region Provides the Possibility of Detecting β-Barrel Pore-Forming Toxins from Various Bacterial Species

Engineering conjugative CRISPR-Cas9 systems for the targeted control of enteric pathogens and antibiotic resistance

Identification of novel toxins associated with the extracellular contractile injection system using machine learning

and validation of cwlM and pbpB essentiality for viability and resistance to imipenem in

Genome-wide screen of infected macrophages identified the GID/CTLH complex as a determinant of intracellular bacterial growth